These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. Packard ER; Parton R; Coote JG; Fry NK J Med Microbiol; 2004 May; 53(Pt 5):355-365. PubMed ID: 15096543 [TBL] [Abstract][Full Text] [Related]
10. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209 [TBL] [Abstract][Full Text] [Related]
11. Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines. Zomer A; Otsuka N; Hiramatsu Y; Kamachi K; Nishimura N; Ozaki T; Poolman J; Geurtsen J Microb Genom; 2018 May; 4(5):. PubMed ID: 29771235 [TBL] [Abstract][Full Text] [Related]
12. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. Hegerle N; Dore G; Guiso N Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274 [TBL] [Abstract][Full Text] [Related]
13. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination. Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013 [TBL] [Abstract][Full Text] [Related]
14. Pertussis Resurgence Associated with Pertactin-Deficient and Genetically Divergent Bordetella Pertussis Isolates in Israel. Bamberger E; Abu Raya B; Cohen L; Golan-Shany O; Davidson S; Geffen Y; Srugo I Pediatr Infect Dis J; 2015 Aug; 34(8):898-900. PubMed ID: 25966915 [TBL] [Abstract][Full Text] [Related]
15. Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis. Ma L; Caulfield A; Dewan KK; Harvill ET Emerg Infect Dis; 2021 Jun; 27(6):1561-1566. PubMed ID: 34014152 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003. Byrne S; Slack AT BMC Infect Dis; 2006 Mar; 6():53. PubMed ID: 16542440 [TBL] [Abstract][Full Text] [Related]
17. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837 [TBL] [Abstract][Full Text] [Related]
18. Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis. Weigand MR; Pawloski LC; Peng Y; Ju H; Burroughs M; Cassiday PK; Davis JK; DuVall M; Johnson T; Juieng P; Knipe K; Loparev VN; Mathis MH; Rowe LA; Sheth M; Williams MM; Tondella ML Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358336 [TBL] [Abstract][Full Text] [Related]
19. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014. Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959 [TBL] [Abstract][Full Text] [Related]